Strategic partnerships Brevitas recently partnered with ValGenesis to offer enterprise validation lifecycle management capabilities, indicating a readiness to combine consulting expertise with specialized lifecycle software to deliver end-to-end CQV and CSV solutions.

Life science focus With a mission to accelerate product delivery for life science companies and a broad CQV, CSV, regulatory, and quality service footprint, Brevitas is well positioned to target pharma, biotech, and medical device segments seeking compliance-driven project outcomes.

Compliance and data integrity Strong emphasis on data integrity, quality, regulatory affairs, and change management signals opportunities to offer integrated QA/CSV packages, GMP-aligned consulting, and training programs for validated systems and audits.

Technology stack leverage Proficiency in JMP, SAP, Google Cloud, AWS and other analytics and cloud platforms presents avenues to upsell data analytics, cloud-based compliance, and validated system implementations for life sciences clients migrating to modern infrastructure.

Growth potential Mid-market size with revenue in the 25–50M and 51–200 employees indicates scope for expanding service lines (training, lean six sigma, QC audits) and cross-selling to existing clients in regulatory, cybersecurity, and process optimization initiatives.